|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 October 2017 |
|
Main ID: |
NCT00000378 |
|
Date of registration:
|
02/11/1999 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Antidepressant Treatment of Melancholia in Late Life
|
|
Scientific title:
|
Antidepressant Treatment of Melancholia in Late :Ife |
|
Date of first enrolment:
|
July 1997 |
|
Target sample size:
|
110 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT00000378 |
|
Study type:
|
Interventional |
|
Study design:
|
|
|
Phase:
|
Phase 4
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Steven P. Roose, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
New York State Psychiatric Institute |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
Patients must have:
Unipolar major depression (per Diagnostic and Statistical Manuel-IV criteria) with or
without melancholia.
Exclusion Criteria:
Patients with the following symptoms or conditions are excluded:
Psychotic or atypical subtype of unipolar major depression.
Age minimum:
60 Years
Age maximum:
95 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Depression
|
|
Melancholia
|
|
Intervention(s)
|
|
Drug: Nortriptyline
|
|
Drug: Sertraline
|
|
Primary Outcome(s)
|
|
HAMILTON Rating Scale for DEPRESSION Range
[Time Frame: BASELINE COMPARED TO 12 WEEK MEASUREMENT]
|
|
Secondary ID(s)
|
|
R01MH055716
|
|
#3105
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|